Advertisement

Topics

Global Kinetics Corporation Company Profile

07:58 EDT 20th March 2019 | BioPortfolio

Global Kinetics Corporation (GKC) is a privately held technology company headquartered in Australia focused on globally commercialising its innovative movement disorder technology, specifically for the treatment of Parkinson’s Disease. The company’s lead product is the Parkinson’s KinetiGraph (PKG), a first in class medical technology enabling neurologists to better manage the key disabling movement symptoms of Parkinson’s.


News Articles [282 Associated News Articles listed on BioPortfolio]

Global Kinetics’ PKG smartwatch provides clinically meaningful improvement in PD symptom assessment

The PKG device is a wearable technology that offers clinicians with a passive, continuous, objective, ambulatory assessment of the treatable and disabling symptoms of PD, including bradykinesia, dyski...

Another 510(k) for Neuro Kinetics

(Neuro Kinetics, Inc.) Neuro Kinetics, Inc. (NKI), announced that they received another 510(k) clearance from the United States Food and Drug Administration (FDA) for important efficiency features to ...

Orion Corporation: Managers' transactions - Olli Huotari

ORION CORPORATION         MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Olli Huotari Orion Corporation has received the ...

Orion Corporation: Managers' transactions - Virve Laitinen

ORION CORPORATION      MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Virve Laitinen Orion Corporation has received the f...

Orion Corporation: Managers' transactions - Satu Ahomäki

ORION CORPORATION     MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Satu Ahomäki   Orion Corporation has received the fo...

Orion Corporation: Managers' transactions - Christer Nordstedt

 ORION CORPORATION        MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Christer Nordstedt Orion Corporation has receiv...

Orion Corporation: Managers' transactions - Timo Lappalainen

ORION CORPORATION     MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Timo Lappalainen Orion Corporation has received...

Orion Corporation: Managers' transactions - Jari Karlson

ORION CORPORATION      MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Jari Karlson Orion Corporation has received the fol...

PubMed Articles [1107 Associated PubMed Articles listed on BioPortfolio]

Two-state folding of the outer membrane protein X into a lipid bilayer membrane.

Folding and insertion of β-barrel membrane proteins into native membranes is efficiently catalyzed by β-barrel assembly machineries. Understanding this catalysis requires a detailed description of t...

Variable diffusivity homogeneous surface diffusion model and analysis of merits and fallacies of simplified adsorption kinetics equations.

Adsorption and ion exchange phenomena are encountered in several separation processes, which in turn, are of vital importance across various industries. Although the literature on adsorption kinetics ...

Global surgery and the sustainable development goals.

The field of global surgery has gained significant recent momentum, catalysed by the 2015 publication of the Lancet Commission on Global Surgery, Disease Control Priorities 3 and World Health Assembly...

Study of kinetics of F-MRI using a fluorinated imaging agent (FIT) on a 3T clinical MRI system.

To use F imaging tracer (FIT-27) to evaluate kinetics in major organs.

Analysis of the dissipation kinetics of thiophanate-methyl and its metabolite carbendazim in apple leaves using a modified QuEChERS-UPLC-MS/MS method.

As one of the main fungicides for the apple leaf disease control, thiophanate-methyl (TM) mainly exerts the fungicidal activity in the form of its metabolite carbendazim (MBC), whose dissipation kinet...

Clinical Trials [1300 Associated Clinical Trials listed on BioPortfolio]

Human CNS Tau Kinetics in Tauopathies

The goal of this study is to characterize tau kinetics and tau aggregation in the human CNS and to test the hypothesis that tau kinetics are altered (i.e. increased production, decreased c...

Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan

Hepatitis C virus (HCV) infection is a global health problem, which may lead to chronic hepatitis, cirrhosis, hepatic decompensation and hepatocellular carcinoma (HCC). Recently, treatment...

Vitamin A Kinetics and Mathematical Modeling in American Women

Women were given a vitamin A tracer, and blood was sampled to determine individual and group vitamin A kinetics. Data were subsequently modeled using compartmental analysis to determine ef...

Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 3-202 and Metabolites

The purpose of this study is: To determine the rate and routes of excretion of BIA 3-202 and the mass balance in urine and faeces To determine the kinetics of total radioactivity in blood...

Kinetics of Serum β-D-glucan During Peritonitis With Candida in Resuscitation

Intraabdominal fungal infections with Candida are constantly increasing. Their diagnosis and treatment is difficult. Morbidity and mortality are high. Β-D-Glucan has been proposed as a ma...

Companies [1006 Associated Companies listed on BioPortfolio]

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

NEC Corporation of America

NEC Corporation of America (NEC) is a leading technology integrator providing solutions that improve the way people work and communicate. NEC delivers integrated Solutions for Soc...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

Insulet Corporation

Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its Omnipod Insulin Management Sys...

Protective Life Corporation

Protective Life Corporation provides financial services through the production, distribution and administration of insurance and investment products throughout the U.S. The compan...

More Information about "Global Kinetics Corporation" on BioPortfolio

We have published hundreds of Global Kinetics Corporation news stories on BioPortfolio along with dozens of Global Kinetics Corporation Clinical Trials and PubMed Articles about Global Kinetics Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Global Kinetics Corporation Companies in our database. You can also find out about relevant Global Kinetics Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...


Corporate Database Quicklinks



Searches Linking to this Company Record